Posted by Michael Wonder on 31 Oct 2017
Proposal to widen access to zoledronic acid for early breast cancer
31 October 2017 - PHARMAC proposes to widen funded access to zoledronic to include adjuvant use in post-menopausal women with early breast cancer.
Consultation on this proposal closes at 5 pm on Tuesday, 14 November 2017.
